Health-related quality of life after surgery for primary advanced rectal cancer and recurrent rectal cancer: A review

Colorectal Disease

Volumn 14, Issue 7, 2012, Pages 797-803

  Thaysen, H V ^a   Jess, P ^b,c   Laurberg, S ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b ROSKILDE HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Colorectal surgery; Health related quality of life; Rectal cancer; Recurrent rectal cancer

Indexed keywords

ADVANCED CANCER; CANCER RECURRENCE; CANCER SURGERY; CROSS-SECTIONAL STUDY; HUMAN; LONGITUDINAL STUDY; PRIMARY TUMOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RECTUM CANCER; RECTUM SURGERY; REVIEW; SEXUAL FUNCTION; SOCIAL STATUS;

HUMANS; NEOPLASM RECURRENCE, LOCAL; QUALITY OF LIFE; RECTAL NEOPLASMS;

EID: 84862135689     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2011.02668.x     Document Type: Review

References (29)

1. Lopez MJ, Spratt JS. Exenterative pelvic surgery. J Surg Oncol 1999; 72: 102-14.
2. Eriksen MT, Wibe A, Hestvik UE, Haffner J, Wiig JN. Surgical treatment of primary locally advanced rectal cancer in Norway. Eur J Surg Oncol 2006; 32: 174-80.
3. Palmer G, Martling A, Blomquist L, Cedermark B, Holm T. Outcome after the introduktion of a multimodality treatment program for locally advanced rectal cancer. Eur J Surg Oncol 2005; 31: 727-34.
4. Ferenschild FT, Vermaas M, Verhoef C et al. Total pelvic exenteration for primary and recurrent malignancies. World J Surg 2009; 33: 1502-8.
5. Gannon CJ, Zager JS, Chang GJ et al. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma. Ann Surg Oncol 2007; 14: 1870-7.
6. Vermaas M, Ferenschild FT, Verhoef C et al. Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer. Eur J Surg Oncol 2007; 33: 452-8.
7. Crowe PJ, Temple WJ, Lopez MJ, Ketcham AS. Pelvic exenteration for advanced pelvic malignancy. Semin Surg Oncol 1999; 17: 152-60.
8. Palmer G, Martling A, Cedermark B, Holm T. A population-based study on the management and outcome in patients with locally recurrent rectal cancer. Ann Surg Oncol 2007; 14: 447-54.
9. Bakx R, Visser O, Josso J et al. Management of recurrent rectal cancer: a population based study in greater Amsterdam. World J Gastroenterol 2008; 14: 6018-23.
10. Nielsen MB, Laurberg S, Holm T. Current management of locally recurrent rectal cancer. Colorectal Dis 2011; 13: 732-42.
11. Fayers PM, Machin D. (2008) Introduction. In: Quality of Life. The Assessment, Analysis and Interpretation of Patient-Reported Outcome, pp. 3-30. John Wiley and Sons, Chichester, England.
12. Bottomley A, Flechtner H, Efficace F et al. Health related quality of life outcomes in cancer clinical trials. Eur J Cancer 2005; 41: 1697-709.
13. Palmer G. (2009) Locally Advanced Rectal Cancer. Aspects of Management, Outcome and Quality of Life, pp. 17-34. Colorectal Surgery Research Group, Karolinska Institutet, Stockholm, Sweden.
14. Oxford-Centre for Evidence-based Medicine. (2010) Levels of Evidence and Grades of Recommendation. Available from: (accessed November 2010).
15. Palmer G, Martling A, Lagergren P, Cedermark B, Holm T. Quality of life after potentially curative treatment for locally advanced rectal cancer. Ann Surg Oncol 2008; 15: 3109-17.
16. Guren MG, Wiig JN, Dueland S et al. Quality of life in patients with urinary diversion after operation for locally advanced rectal cancer. Eur J Surg Oncol 2001; 27: 645-51.
17. Zoucas E, Frederiksen S, Lydrup ML et al. Pelvic exenteration for advanced and recurrent malignancy. World J Surg 2010; 34: 2177-84.
18. Austin KK, Young JM, Solomon MJ. Quality of life of survivors after pelvic exenteration for rectal cancer. Dis Colon Rectum 2010; 53: 1121-6.
19. Esnaola NF, Cantor SB, Johnson ML et al. Pain and quality of life after treatment in patients with locally recurrent rectal cancer. J Clin Oncol 2002; 20: 4361-7.
20. Wright FC, Crooks D, Fitch M et al. Qualitative assessment of patient experiences related to extended pelvic resection for rectal cancer. J Surg Oncol 2006; 93: 92-9.
21. Davidge KM, Eskicioglu C, Lipa J et al. Qualitative assessment of patient experiences following sacrectomy. J Surg Oncol 2010; 101: 447-50.
22. Aaronson NK, Ahmedzai S, Bergman B et al. The European-Organization-For-Research-And-Treatment-Of-Cancer Qlq-C30 - A Quality-Of-Life Instrument for Use in International Clinical-Trials in Oncology. J Natl Cancer Inst 1993; 85: 365-76.
23. Jess P, Iversen LH, Nielsen MB et al. Quality of life after cytoreductive surgery plus early intraperitoneal postoperative chemotherapy for pseudomyxoma peritonei: a prospective study. Dis Colon Rectum 2008; 51: 868-74.
24. Camilleri-Brennan J, Steele RJ. Prospective analysis of quality of life and survival following mesorectal excision for rectal cancer. Br J Surg 2001; 88: 1617-22.
25. Allal AS, Gervaz P, Gertsch P et al. Assessment of quality of life in patients with rectal cancer treated by preoperative radiotherapy: a longitudinal prospective study. Int J Radiat Oncol Biol Phys 2005; 61: 1129-35.
26. Pachler J, Wille-Jorgensen P. Quality of life after rectal resection for cancer, with or without permanent colostomy. Cochrane Database Sys Rev 2005; CD004323.
27. Schwartz CE, Sprangers MA. Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research. Soc Sci Med 1999; 48: 1531-48.
28. Schwartz CE, Sprangers MA. Reflections on genes and sustainable change: toward a trait and state conceptualization of response shift. J Clin Epidemiol 2009; 62: 1118-23.
29. Fayers PM, Aaronson NK, Bjordal K et al. (2001 3rd edition) The EORTC QLQ-C30 Scoring Manual. European Organisation for Research and Treatment of Cancer, Brussels.